Dexbrompheniramine
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313407This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19BrN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75T64B71RP, chemically known as 3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-yl-propan-1-amine but generally known as dexbrompheniramine, which bears US NIH Compound Identifier 16960. European Medicines Agency schedules Dexbrompheniramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07021MIG. World Health Organization schedules dexbrompheniramine in its Anatomical Therapeutic Chemical (ATC) Classification. DEXBROMPHENIRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexbrompheniramine under HS 29333999 and SITC 51574. As of Q4 2014, DEXBROMPHENIRAMINE remains the US FDA Preferred Term for this commodity. Dexbrompheniramine bears US NLM identifiers UMLS ID C0057605 and NCI Concept Code C61705. SMILES: BRC1CCC(C(CCN(C)C)C2NCCCC2)CC1.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.